Evaluation of the effect of gabapentin in reducing pain

The effect of preoperative administration of gababentin to prevent or reduce pain following laparoscopy of advanced endometriosis

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20150817023666N14

Enrollment

140

Registered

2021-04-21

Start date

2021-05-22

Completion date

Unknown

Last updated

2021-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Reduction of pain after laparoscopic endometriosis surgery.

Interventions

Intervention 1: Intervention group: In the intervention group, 600 mg of gabapentin with 30 cc of water is given to the patient one hour before the operation. Intervention 2: Control group: In the con

Eligibility

Sex/Gender

Female

Age

16 Years to 40 Years

Inclusion criteria

Inclusion criteria: Endometriosis patients aged 16-40 years in Stage 3 and 4 diseases

Exclusion criteria

Exclusion criteria: Kidney and liver patients patients with gabapentin allergy patients with mental disorders and epilepsy patients who have taken painkillers and any drugs and cigarettes one week before surgery

Design outcomes

Primary

Measure	Time frame
Reduction of pain and drug use after laparoscopic surgery. Timepoint: 6, 12 and 24 hours after surgery. Method of measurement: Pain questionnaire based on Visual Analogue Scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAbolfazl Mehdizadeh Kashi

Iran University of Medical Sciences

mehdizadeh.a@iums.ac.ir+98 21 6435 1000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026